share_log

奥本海默:维持Pharvaris(PHVS.US)评级

Stock Star ·  Jul 3 08:23

奥本海默:维持pharvaris(PHVS.US)评级,由优于大市调整至优于大市评级,目标价由36.00美元调整至38.00美元。

Pharvaris(PHVS.US)公司简介:Pharvaris NV是一家临床阶段的公司。它专注于发现、开发和商业化治疗具有重大未满足需求的罕见疾病,最初专注于血管性水肿和其他缓激肽介导的疾病。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment